Skip To The Main Content
Parenteral Drug Association Connecting People, Science and Regulation ®

Journal Top 10

Jul 03, 2018

Particulate Matter Still a Popular Topic in the PDA Journal

Below are the top ten articles from the PDA Journal of Pharmaceutical Science and Technology for the month of April.

  1. PDA Paper. Deborah M. Autor, et al., “PDA Points to Consider: Best Practices for Document/Data Management and Control and Preparing for Data Integrity Inspections,” Feb. 14, 2018 (accepted article)
  2. Review. Stephen E. Langille, “Particulate Matter in Injectable Drug Products,” May/June 2013
  3. PQRI Special Section – Research. Dennis Jenke, et al., “Extractables Characterization for Five Materials of Construction Representative of Packaging Systems Used for Parenteral and Ophthalmic Drug Products,” September/October 2013
  4. PDA Paper. Stan Bukofzer, et al., “Industry Perspective on the Medical Risk of Visible Particles in Injectable Drug Products,” January/February 2013
  5. PQRI Special Section – Review. Diane Paskiet, et al., “The Product Quality Research Institute (PQRI) Leachables and Extractables Working Group Initiatives for Parenteral and Ophthalmic Drug Product (PODP),” September/October 2013
  6. Review. Anil K. Rattan, “Data Integrity: History, Issues, and Remediation of Issues,” March/April 2018
  7. Technology/Application Bert Gunter, et al., “A Risk Index and Data Display for Process Performance in the Pharmaceutical Industry,” March/April 2018
  8. Research. Qingyu Zeng and Xia Zhao, “Time-Dependent Testing Evaluation and Modeling for Rubber Stopper Seal Performance,” March/April 2018
  9. Research. Benson Gikanga, Ada Hui and Yuh-Fun Maa, “Mechanistic Investigation on Grinding-Induced Subvisible Particle Formation during Mixing and Filling of Monoclonal Antibody Formulations,” March/April 2018
  10. Research. Ganapathy Gopalrathnam, et al., “Impact of Stainless Steel Exposure on the Oxidation of Polysorbate 80 in Histidine Placebo and Active Monoclonal Antibody Formulation,” March/April 2018

Conversations

comments powered by Disqus